Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug development journey with well characterized in vitro and in vivo disease models in addition to general drug development services, providing valuable insights into the mode of action, pharmacokinetics, safety, and efficacy of investigational compounds. Our services are designed with personalized tailoring in mind, supported by innovative technical capabilities and are executed in close collaboration with our partners. With a focus on nephrology, immuno-oncology, neurology and cardiometabolic disease, our current models include a growing selection of genetic and induced disease models. InnoSer enhances these offerings by providing state-of-the-art imaging and digital pathology options, along with facility management and support services including colony management.